Professor Dan Chambers (Brisbane)
Professor Dan Chambers is a Thoracic and Transplant Physician with long-standing clinical and research interests in lung fibrosis. Dan is Associate Director of the International Lung and Heart-lung Transplant Registry and runs one of the largest pulmonary fibrosis clinical trials centres in Australia. His research has been supported by over $18 million in competitive grant funding. He has been principal investigator for multiple trials from phases 1 to 3 in lung fibrosis, cellular therapy and lung transplantation.
Dan graduated from the University of Queensland, before undertaking much of his specialist and transplant training in the UK. He co-founded the Western Australian lung transplant program before returning to Brisbane in 2008. Dan is Chair of Pulmonary Fibrosis Australasian Clinical Trials Network (PACT).
Associate Professor Tamera Corte (Sydney)
Associate Professor Tamera Corte is a Consultant Respiratory Physician and Director of Interstitial Lung Disease at Royal Prince Alfred Hospital, Sydney. Tamera is an Associate Professor at the University of Sydney and is the Chair of the Steering Committee for the Australian Idiopathic Pulmonary Fibrosis Registry and the Australasian Interstitial Lung Disease Registry, and a member of multiple international task forces.
A/Prof. Corte served as Clinical Fellow in Interstitial Lung Disease at the Royal Brompton Hospital in London and has a PhD in the identification of pulmonary vascular dysfunction in interstitial lung disease. She continues her research at Sydney University, where she is Chief Investigator on a Centre of Excellence NHMRC grant for Pulmonary Fibrosis.
Associate Professor Ian Glaspole (Melbourne)
Associate Professor Ian Glaspole is the head of the Alfred Hospital interstitial lung disease clinic and an adjunct clinical associate professor within the Monash University Faculty of Medicine. His research is principally to do with clinical aspects of interstitial lung disease. He is the co-Chair of the Australian Idiopathic Pulmonary Fibrosis Registry, which has formed an important part of a number of NHMRC funded projects, including the Centre for Research Excellence in Pulmonary Fibrosis, and co-Chair of the Australasian Interstitial Lung Disease Registry.
Associate Professor Nicole Goh (Melbourne)
Associate Professor Nicole Goh is a Consultant Respiratory Physician and Director of the Interstitial Lung Disease Unit at Austin Health, Chair of the Medical and Scientific Research Committee at the Institute of Breathing and Sleep. Nicole is Chair of the Rare Lung Disease Network, Lung Foundation Australia and is on the Steering Committees for the Australian Idiopathic Pulmonary Fibrosis Registry and Australasian Interstitial Lung Disease Registry.
Dr Goh served as Clinical Fellow in Interstitial Lung Disease at the Royal Brompton Hospital in London and has a PhD in the identification of prognostic markers in scleroderma associated interstitial lung disease. She continues her research at Austin Health and has a particular interest in pulmonary rehabilitation and oxygen therapy in interstitial lung disease.
Professor Anne Holland (Melbourne)
Professor Anne Holland is Professor of Physiotherapy and Head of Respiratory Research at Alfred Health in Melbourne, a joint appointment with Monash University. Her research program aims to optimise non-pharmacological management for people with chronic respiratory disease.
Anne led the first randomized controlled trial of pulmonary rehabilitation for people with pulmonary fibrosis, a treatment that is now recommended in clinical guidelines across the world. Her current clinical trials investigate new models of pulmonary rehabilitation to improve access and uptake, and ambulatory oxygen therapy for pulmonary fibrosis. In the CRE for Pulmonary Fibrosis she leads programs to optimize patient education and support, and improve translation of research into best clinical practice.
Dr John Mackintosh (Brisbane)
Dr John Mackintosh is a Respiratory and Lung Transplant Physician at The Prince Charles Hospital, Brisbane. In 2018, John completed a clinical fellowship in interstitial lung disease at the prestigious Royal Brompton Hospital, London.
John has a keen interest in familial pulmonary fibrosis and the genetics of interstitial lung disease. He is a strong advocate for patients with interstitial lung disease and is passionate about the multi-disciplinary approach to these patients. He is the principal investigator at the lead site of an investigator-led clinical trial of danazol in people with pulmonary fibrosis related to telomere shortening (TELO-SCOPE).
Professor Andrew Palmer (Hobart)
Professor Andrew Palmer has over 24 years’ experience in the area of health economics research, and is widely published and internationally respected. He studied medicine at the University of Tasmania, worked at the Launceston General Hospital, then as a general practitioner in Sydney. In 1994 he moved to Switzerland, where he was Medical Director of the Institute for Medical Informatics and Biostatistics and co-founded CORE, Center for Outcomes Research in Basel, Switzerland.
Andrew is the Founding Chair of Health Economics at the Menzies Institute for Medical Research, University of Tasmania, and is the Public Health and Primary Care theme leader. He leads the health economics studies of the Centre of Excellence NHMRC grant for Pulmonary Fibrosis.
Associate Professor Lauren Troy (Sydney)
Associate Professor Lauren Troy is a Consultant Respiratory Physician at Royal Prince Alfred Hospital and Chris O’Brien Lifehouse, and a Clinical Associate Professor at the University of Sydney. She sits on the TSANZ Domiciliary Oxygen task force and international task forces for Idiopathic Pulmonary Fibrosis/ Progressive Pulmonary Fibrosis, and Transbronchial Cryobiopsy for ILD diagnosis. Lauren was the chief investigator of the internationally renowned COLDICE Study, comparing cryobiopsy and surgical lung biopsy for ILD diagnosis.
Lauren completed her PhD in exercise and sleep physiology in ILD and her clinical and research interests include ILD, interventional pulmonology, COVID-19 infection and long-term outcomes, bronchiectasis and education.
Professor Margaret Wilsher (Auckland)
Professor Margaret Wilsher is respiratory physician and Chief Medical Officer, Auckland District Health Board and Honorary Professor, University of Auckland. She trained at Otago University, Green Lane Hospital and the Royal Brompton Hospital/National Heart and Lung Institute developing a career long interest in interstitial lung diseases with current research interests in sarcoidosis and the ageing lung. Professor Wilsher also sits on a number of national and Ministerial boards and committees in New Zealand including the advisory board for the NZ Health Research Strategy.
Dr Alison Hey-Cunningham (Sydney)
Dr Alison Hey-Cunningham is the Project Manager of PACT and the Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF). In this role, Alison supports PACT and the CRE-PF through coordination of day-to-day activities to facilitate collaboration between members and the implementation and delivery of research and communication strategies.
Alison completed her PhD in women’s health at the Sydney Medical School, the University of Sydney. Prior to joining the CRE-PF team, Alison worked as a research fellow in The University of Sydney Central Clinical School, Faculty of Medicine and Health developing, managing and undertaking a range of research projects in women’s health and higher education.